Your browser doesn't support javascript.
loading
A Phase I Study of Apolizumab, an Anti-HLA-DR ß-chain Monoclonal Antibody, in Patients With Solid Tumor Malignancies.
Fracasso, Paula M; Goodner, Sherry A; Wildi, Jonathan D; Naughton, Michael J; Linette, Gerald P; Govindan, Ramaswamy; Tan, Benjamin R; Blum, Kristie A; Jones, Gary J; Pearce, Tillman E; Levitt, Daniel J; Clamon, Gerald H.
Afiliação
  • Fracasso PM; Department of Medicine, Washington University School of Medicine and the Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, St. Louis, MO.
  • Goodner SA; Department of Medicine, Washington University School of Medicine and the Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, St. Louis, MO.
  • Wildi JD; Department of Medicine, Washington University School of Medicine and the Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, St. Louis, MO.
  • Naughton MJ; Department of Medicine, Washington University School of Medicine and the Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, St. Louis, MO.
  • Linette GP; Department of Medicine, Washington University School of Medicine and the Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, St. Louis, MO.
  • Govindan R; Department of Medicine, Washington University School of Medicine and the Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, St. Louis, MO.
  • Tan BR; Department of Medicine, Washington University School of Medicine and the Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, St. Louis, MO.
  • Blum KA; Department of Medicine, Washington University School of Medicine and the Alvin J. Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine, St. Louis, MO.
  • Jones GJ; PDL BioPharma Inc., Freemont, CA.
  • Pearce TE; PDL BioPharma Inc., Freemont, CA.
  • Levitt DJ; PDL BioPharma Inc., Freemont, CA.
  • Clamon GH; Department of Internal Medicine, University of Iowa Hospital and Clinics, Iowa City, IA.
Am J Clin Oncol ; 45(7): 294-297, 2022 07 01.
Article em En | MEDLINE | ID: mdl-35700081
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais / Neoplasias Limite: Humans Idioma: En Revista: Am J Clin Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Macau
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Neoplasias Renais / Neoplasias Limite: Humans Idioma: En Revista: Am J Clin Oncol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Macau